Table 2.
Treatment Group, No. (%) | |||
---|---|---|---|
Complication | Nonoperative (n = 41) | Operative (n = 123) | P Value |
Any complication | 7 (17) | 17 (14) | .61 |
Arthrofibrosis | 0 (0) | 11 (8.9) | .047 |
Instrumentation complication | 0 (0) | 1 (0.81) | .56 |
Ipsilateral new ACL injury | 2 (4.9) | 0 (0) | .01 |
Ipsilateral new TSF | 2 (4.9) | 0 (0) | .01 |
Leg-length discrepancy | 0 (0) | 2 (1.6) | .41 |
Nonunion | 1 (2.4) | 0 (0) | .08 |
Persistent pain | 1 (2.4) | 2 (1.6) | .74 |
Superficial infection | 0 (0) | 1 (0.81) | .56 |
aACL, anterior cruciate ligament; TSF, tibial spine fracture.